This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Nov;78(5):760.

doi: 10.1053/j.ajkd.2021.07.006. Epub 2021 Aug 13.

Finerenone: Fiddling With Hyperkalemia?

Joshua Waitzman¹, Mark Canney², Swapnil Hiremath²

Affiliations

PMID: 34400243
DOI: 10.1053/j.ajkd.2021.07.006

Comment

Finerenone: Fiddling With Hyperkalemia?

Joshua Waitzman et al. Am J Kidney Dis. 2021 Nov.

. 2021 Nov;78(5):760.

doi: 10.1053/j.ajkd.2021.07.006. Epub 2021 Aug 13.

Authors

Joshua Waitzman¹, Mark Canney², Swapnil Hiremath²

Affiliations

¹ Beth Israel Deaconess Medical Center, Boston, Massachusetts.
² Department of Medicine, University of Ottawa, Ottawa, Canada.

PMID: 34400243
DOI: 10.1053/j.ajkd.2021.07.006

No abstract available

PubMed Disclaimer

Comment in

In Reply to 'Finerenone: Fiddling With Hyperkalemia?'.
Sridhar VS, Liu H, Cherney DZI. Sridhar VS, et al. Am J Kidney Dis. 2021 Nov;78(5):760-761. doi: 10.1053/j.ajkd.2021.08.001. Epub 2021 Aug 13. Am J Kidney Dis. 2021. PMID: 34400242 No abstract available.

Comment on

Finerenone-A New Frontier in Renin-Angiotensin-Aldosterone System Inhibition in Diabetic Kidney Disease.
Sridhar VS, Liu H, Cherney DZI. Sridhar VS, et al. Am J Kidney Dis. 2021 Aug;78(2):309-311. doi: 10.1053/j.ajkd.2021.02.324. Epub 2021 Mar 19. Am J Kidney Dis. 2021. PMID: 33753202 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science